(GSK Newborn 1) Randomized, Double-Blind, Multicenter, Phase III Study Comparing the Efficacy and Safety of Retosiban Versus Placebo for Woman in Spontaneous Preterm Labor

Project: Other project

StatusFinished
Effective start/end date5/15/155/14/17

Funding

  • GlaxoSmithKline Pharmaceuticals: $5,461.54